Building and Maintaining Quality in Clinical Trial Performance
| FDA Inspections of Clinical Research Sites and Sponsors
Building and Maintaining Quality in Clinical Trial Performance Wednesday, April 10, 2013 5:30 – 8:30 pm Location: AMO Headquarters Program Managers: Terrie Hopton, Manager, Business Development and Special Projects, Promedica International Helene Spencer, Consultant, ClinReg Consulting Services, Inc. Host: Tammy Vu, Regulatory Affairs Specialist, Global RA, Abbott Medical Optics Inc. Schedule 5:30 – 6:30 pm Registration and Networking Dinner 6:30 – 7:30 pm What FDA Looks for in Clinical Study Site Inspections Speaker: Gene Arcy, Consumer Safety Officer and BIMO Inspector, FDA Los Angeles District
7:30 – 8:30 pm What Sponsors (and Sites) Should Be Doing to Assure Study Protocol and GCP Compliance Speaker: Ginger Clasby, Vice President, Clinical & Regulatory Affairs, Transcend Medical Inc.
Synopsis: The implementation and maintenance of high quality clinical programs is an expensive, time-consuming and hugely important activity for sponsors who will need study results for regulatory submissions or market expansion. Key factors include: * A variety of personnel, logistical and regulatory elements must be budgeted for, contracted and coordinated efficiently. * A thoughtful plan should be in place to recruit qualified study participations in a timely manner – and to keep them actively involved throughout their participation in the study. * Clinical data supporting study objectives must be captured and maintained in a manner that protects data integrity and is relatively simple for study sites to do. * A system should be in place to promptly and thoroughly evaluate and report safety events, as appropriate. * And, depending on the nature and duration of the study, there are the challenges of “cutting in” protocol modifications, managing changes in data capture requirements, study team turnover and the accompanying overall “study fatigue” experienced by study sites and sponsor work teams. At this meeting, using a combination of didactic and case studies presentations, we will discuss best practices for clinical study start-up and ongoing implementation to ensure study quality and review how FDA inspectors confirm the adequacy of GCP and protocol compliance. About the Speakers: Gene Arcy has been an FDA Consumer Safety Officer for 13 years. HIs experience includes: · Biologics Specialist · HCT/Ps Inspection Program Monitor (HCT/Ps = Human Cellular and Tissue-Based Products) for Los Angeles District (HCT/Ps regulated by CBER = Center for Biologics Evaluation and Research) · Medical Device Inspection Program Monitor (CBER approved/cleared devices only) for Los Angeles District · Also specialize in the inspection of tissue-based devices that have been cleared by CDRH, and conduct routine inspections of other non-tissue based medical devices (Not sure how you want to word this). · Performed Biomedical Monitoring (BIMO) inspections of clinical investigators under the GCPs to a large extent, and performed inspections of sponsor and IRBs. Also experienced conducting GLP inspections. Gene has a M.S. in Quality Assurance-Manufacturing and served on Air Force active duty and Retired from the Air Force National Guard – Clinical Laboratory Supervisor. Ginger Clasby has worked in the field of regulated medical products for more than 25 years. Introduced to ophthalmic devices when she began employment with American Medical Optics (AMO) in 1978, she worked with the company for nine years in various capacities as the companyʼs business expanded: Biostatistician, Quality Assurance Manager, Production Manager – Intraocular Lenses (IOLs), Manufacturing Engineering Manager, Plant Manager and Product & Marketing Manager – IOLs. Subsequent to her employment with AMO, she joined the ophthalmic surgical products divisionʼs executive team at Optical Radiation Corporation (ORC). There, as Vice President of Sales and Marketing, she was responsible for worldwide marketing and domestic sales of the divisionʼs Class III ophthalmic surgical products for five years. In 1994, she joined Promedica International, a specialty contract research organization (CRO). As a pivotal executive in this privately-owned firm, she built the companyʼs clinical regulatory division from ground up, establishing the organization as a respected, major provider of clinical research services within the ophthalmic and medical device market sectors. During her 15 year tenure there, she served as Vice President, Clinical & Regulatory and also as Executive Vice President, Business Development. Ginger joined Transcend Medical in 2009. As Vice President, Clinical & Regulatory Affairs, she is responsible for overseeing clinical operations and regulatory processes associated with implementation and ongoing management of the companyʼs pivotal US IDE trial as well as additional trials underway in Europe. She holds the MS degree in Industrial Engineering from Arizona State University and BS degrees in Mathematics & Physics from Guilford College. She is the current President of OCRA and serves on the University of California-Irvine Extension Life Science Advisory Committee and the California State University Program for Education & Research in Biotechnology Advisory Board. Cost: $50 OCRA Members $100 Non Members (includes one year Membership to OCRA) $25 Student/Government Rate OCRA REGISTRATION INSTRUCTIONS FDA Inspections of Clinical Research Sites and Sponsors Wednesday, April 10, 2013
Registration fee includes dinner, free parking at AMO and access to electronic presentations (if approved by speakers for distribution).
Be sure to log on or create a new user profile before registering: http://www.ocra-dg.org/
MULTIPLE REGISTRATIONS: Our system is set up for one registration at a time. To register multiple people from your company, you can simplify the process by faxing us a cover page on your company letterhead listing the names of your attendees along with their title and email address and credit card payment. Please let us know if you want us to process your credit card or hold it until we receive a check. Click Here to Download Event Flyer SINGLE REGISTRATION: Log on to the OCRA Web site with your username and password or create a new user profile: http://www.ocra-dg.org/ Once you are logged on, click on “Register for a Meeting” on the right-hand side of the page. Next click on the meeting for which you would like to register, then follow the online instructions. You will receive an immediate confirmation. If paying by personal or company check: Please register online, then fax your credit card details on your company letterhead to 949-266-8461 to hold your spot. Mail your check made payable to OCRA to the following address: Orange County Regulatory Affairs Discussion Group 5319 University Dr., Suite 641, Irvine, CA 92612 Tel: 949-387-9046 Fax: 949-266-8461 Email: ksyre@cox.net OCRA’s non-profit Federal Tax ID# 33-0630455 Payments and Cancellation Deadline: For a refund, please cancel by emailing Kimberly Syre (ksyre@cox.net) by April 3, 2013. If you have reserved a space but do not attend, your payment MUST be remitted.
DRIVING DIRECTIONS: Abbott Medical Optics (AMO) 1700 E. St. Andrew Place Santa Ana, CA 92705 (714) 247-8200 Directions to AMO from Los Angeles International Airport: – Exit the airport and follow the signs to 405 south (Long Beach) – Continue on 405 for approximately 35 miles – Take the 55 north and exit at Edinger Avenue – Turn left onto Edinger – Turn left on Lyon Street – Turn left on St. Andrew Place and enter the first driveway on the right. Directions to AMO from John Wayne, Orange County Airport: – On exiting the airport, turn left onto MacArthur Boulevard – Take the 55 north and exit at Edinger Avenue – Turn left onto Edinger – Turn left on Lyon Street – Turn left on St. Andrew Place and enter the first driveway on the right. It is recommended that you look up driving directions from your own starting point.
|
